Products & Services · Year Two
Multi-line and other specialty — Year Two
Arch Capital Group Multi-line and other specialty — Year Two decreased by 0.7% to 29.0% in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 0.7%, from 29.2% to 29.0%.
Analysis
StatementSegment
CategoryEfficiency
SignalContext dependent
VolatilityModerate
First reportedQ4 2018
Last reportedQ4 2025
How to read this metric
Consistent development patterns in Year Two suggest stable actuarial assumptions and predictable claim behavior.
Detailed definition
This metric represents the loss development or claims activity specifically for the second year following the inception...
Peer comparison
Standard component of loss development triangles; peers report this as 'Development Year 2'.
Metric ID:
acgl_segment_multi_line_and_other_specialty_year_twoHistorical Data
5 periods
| Q4 '21 | Q4 '22 | Q4 '23 | Q4 '24 | Q4 '25 | |
|---|---|---|---|---|---|
| Value | 29.5% | 28.9% | 29.3% | 29.2% | 29% |
| QoQ Change | — | -2.0% | +1.4% | -0.3% | -0.7% |
| YoY Change | — | -2.0% | +1.4% | -0.3% | -0.7% |
Range28.9% – 29.5%
CAGR-1.7%
Avg YoY Growth-0.4%
Median YoY Growth-0.5%
Current Streak2 quarters decline
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Arch Capital Group's multi-line and other specialty — year two?
- Arch Capital Group (ACGL) reported multi-line and other specialty — year two of 29.0% in Q4 2025.
- How has Arch Capital Group's multi-line and other specialty — year two changed year-over-year?
- Arch Capital Group's multi-line and other specialty — year two decreased by 0.7% year-over-year, from 29.2% to 29.0%.
- What does multi-line and other specialty — year two mean?
- Claims activity and loss development during the second year of the underwriting period.